Literature DB >> 18975377

Interaction of alpha-gliadin with poly(HEMA-co-SS): structural characterization and biological implication.

Li Liang1, Maud Pinier, Jean-Christophe Leroux, Muriel Subirade.   

Abstract

The wheat gluten protein alpha-gliadin, a well known trigger of celiac disease, can be complexed by random copolymers of hydroxyethyl methacrylate (HEMA) and sodium 4-styrene sulfonate (SS). In this work, influence of alpha-gliadin and poly(HEMA-co-SS) concentrations on alpha-gliadin structure was studied using spectroscopic techniques and dynamic light scattering. In 70% ethanol or 0.06M HCl (pH 1.2), alpha-gliadin was found to self-associate upon increasing its concentrations and displayed decreased alpha-helical content and increased beta-turn and beta-sheet contents. At pH 1.2, alpha-gliadin interacted with poly(HEMA-co-SS) to form supra-molecular complex particles. Poly(HEMA-co-SS) induced alpha-gliadin structural changes that mimicked those obtained by varying the protein concentration in pure solution. At pH 6.8, alpha-gliadin was poorly soluble and formed large particles but alpha-helix is still main secondary structure. The influence of the polymer on protein structure was weaker at neutral than acidic pH. Interaction with poly(HEMA-co-SS) disrupted alpha-gliadin conformation and self-association to form new complex particles at neutral pH. This study provides insight into the mechanism of poly(HEMA-co-SS)/alpha-gliadin interaction and the polymer as alpha-gliadin sequestering agents in the supportive treatment of celiac disease. 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18975377     DOI: 10.1002/bip.21109

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  9 in total

Review 1.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

2.  Aqueous RAFT Synthesis of Low Molecular Weight Anionic Polymers for Determination of Structure/Binding Interactions with Gliadin.

Authors:  Ashleigh N Bristol; Brooke P Carpenter; Ashley N Davis; Lisa K Kemp; Vijayaraghavan Rangachari; Shahid Karim; Sarah E Morgan
Journal:  Macromol Biosci       Date:  2020-06-22       Impact factor: 4.979

Review 3.  Novel therapies for coeliac disease.

Authors:  L M Sollid; C Khosla
Journal:  J Intern Med       Date:  2011-06       Impact factor: 8.989

Review 4.  Current and emerging therapies for coeliac disease.

Authors:  Laura Kivelä; Alberto Caminero; Daniel A Leffler; Maria Ines Pinto-Sanchez; Jason A Tye-Din; Katri Lindfors
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-20       Impact factor: 46.802

Review 5.  Current and emerging therapy for celiac disease.

Authors:  Govind K Makharia
Journal:  Front Med (Lausanne)       Date:  2014-03-24

6.  BL-7010 demonstrates specific binding to gliadin and reduces gluten-associated pathology in a chronic mouse model of gliadin sensitivity.

Authors:  Justin L McCarville; Yotam Nisemblat; Heather J Galipeau; Jennifer Jury; Rinat Tabakman; Ad Cohen; Esmira Naftali; Bela Neiman; Efrat Halbfinger; Joseph A Murray; Arivarasu N Anbazhagan; Pradeep K Dudeja; Alexander Varvak; Jean-Christophe Leroux; Elena F Verdu
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 7.  Celiac Disease and Possible Dietary Interventions: From Enzymes and Probiotics to Postbiotics and Viruses.

Authors:  Sandip K Wagh; Karen M Lammers; Manohar V Padul; Alfonso Rodriguez-Herrera; Veronica I Dodero
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

Review 8.  Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy.

Authors:  Jürgen Stein; Detlef Schuppan
Journal:  Viszeralmedizin       Date:  2014-06

Review 9.  New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options.

Authors:  Verónica Segura; Ángela Ruiz-Carnicer; Carolina Sousa; María de Lourdes Moreno
Journal:  Nutrients       Date:  2021-06-23       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.